These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31734955)

  • 41. Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study.
    Vogler S; Vitry A; Babar ZU
    Lancet Oncol; 2016 Jan; 17(1):39-47. PubMed ID: 26670089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparing health care systems: what nations can learn from one another.
    Hsiao WC
    J Health Polit Policy Law; 1992; 17(4):613-36. PubMed ID: 1299683
    [No Abstract]   [Full Text] [Related]  

  • 44. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
    Kesselheim AS; Avorn J; Sarpatwari A
    JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Consistency of new drug pricing in Korea: Bridging variations among personnel in price negotiations.
    Kwon HY; Kim J
    Health Policy; 2020 Sep; 124(9):965-970. PubMed ID: 32660816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strategies to enhance price and quality competition in health care: lessons learned from tracking local markets.
    Lesser CS; Ginsburg PB
    J Health Polit Policy Law; 2006 Jun; 31(3):557-67. PubMed ID: 16785297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does healthcare system device volume correlate with price paid for spinal implants: a cross-sectional analysis of a national purchasing database.
    Cahan E; McFarlane K; Segovia N; Chawla A; Wall J; Shea K
    BMJ Open; 2022 Apr; 12(4):e057547. PubMed ID: 35473724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Ophthalmic Medication Prices Between the United States and Australia.
    Parikh R; Feng PW; Tainsh L; Sakurada Y; Balaratnasingam C; Khurana RN; Hemmati H; Modi YS
    JAMA Ophthalmol; 2019 Apr; 137(4):358-362. PubMed ID: 30629105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medical indigency and economic scarcity: are egalitarian access to care and cost control mutually inconsistent goals?
    Ozenberger L
    Loyola Law Rev; 1987; 33(1):113-42. PubMed ID: 11658970
    [No Abstract]   [Full Text] [Related]  

  • 51. Why even egalitarians should favor market health insurance.
    Shapiro D
    Soc Philos Policy; 1998; 15(2):84-132. PubMed ID: 11657117
    [No Abstract]   [Full Text] [Related]  

  • 52. The heterogeneity of the COVID-19 pandemic and national responses: an explanatory mixed-methods study.
    Chen YY; Assefa Y
    BMC Public Health; 2021 May; 21(1):835. PubMed ID: 33933062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Value-based approaches to healthcare systems and pharmacoeconomics requirements in Asia: South Korea, Taiwan, Thailand and Japan.
    Kamae I
    Pharmacoeconomics; 2010; 28(10):831-8. PubMed ID: 20831290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Limits on Medicaid patients' rights to choose their own doctors and hospitals.
    Dallek G; Wulsin L
    Clgh Rev; 1983 Jul; 17(4):280-9. PubMed ID: 11650691
    [No Abstract]   [Full Text] [Related]  

  • 55. Health care cost containment strategies used in four other high-income countries hold lessons for the United States.
    Stabile M; Thomson S; Allin S; Boyle S; Busse R; Chevreul K; Marchildon G; Mossialos E
    Health Aff (Millwood); 2013 Apr; 32(4):643-52. PubMed ID: 23569043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. User charges and priority setting in health care: balancing equity and efficiency.
    Smith PC
    J Health Econ; 2005 Sep; 24(5):1018-29. PubMed ID: 16129131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The tradeoff between price and quality of services in the Philippines.
    Hotchkiss DR
    Soc Sci Med; 1998 Jan; 46(2):227-42. PubMed ID: 9447645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of European pharmaceutical price regulation on generic price competition: a review.
    Puig-Junoy J
    Pharmacoeconomics; 2010; 28(8):649-63. PubMed ID: 20515079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pricing, demanders, and the supply of health care.
    Maynard A
    Int J Health Serv; 1979; 9(1):121-33. PubMed ID: 422291
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.